Bangladesh to get vaccine in time: Beximco
Published: 02:22 PM, 4 January 2021
As per the agreement, Bangladesh would get coronavirus vaccine from the Seram Institute of India in time, an official of Beximco Pharmaceuticals said on Monday.
Beximco's Chief Operating Officer (COO) Rabbur Reza told reporters that according to the agreement, the Seram Institute will provide the first phase of vaccine within the first month of production after getting the local approval (if Bangladesh approves).
"As a most friendly neighbour of India, Bangladesh is top on the priority list to get the vaccine," he said, adding: "We hope to get the vaccine in time."
According to the agreement - which was signed between Serum Institute, Beximco Pharmaceuticals and the government of Bangladesh - 3 crore doses of vaccine were to be given to Bangladesh in six months at the rate of 5 million doses per month from the first month of production.
The vaccine - developed by Oxford-AstraZeneca - was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn’t export the shots to ensure that vulnerable populations in India are protected, the company’s CEO Adar Poonawalla said in a phone interview with The Associated Press.